StockGuru News: The Immune Response Corporation to Present at the Rodman & Renshaw Eighth Annual Healthcare Conference 2006
The Immune Response Corporation to Present at the Rodman & Renshaw Eighth Annual Healthcare Conference 2006 The Immune Response Corporation (OTCBB: IMNR) IRC to Discuss Upcoming Launch of Phase II NeuroVax(TM) Trial in Patients With Multiple Sclerosis; To Initiate Enrollment Before Year End CARLSBAD, Calif.–(BUSINESS WIRE)–The Immune Response Corporation (OTCBB: IMNR - News), an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases, announced that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New…